{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Inverse exposure, Synthetic replication, Use of derivatives, Daily rebalancing compounding effect",
    "classification": "complex",
    "supporting_data": "The product is a Leverage Shares -5x Short 7-10 Year Treasury Bond ETP Securities, which is a collateralised exchange traded product designed to provide -5 times the daily performance of the iShares 7-10 Year Treasury Bond ETF. This implies significant leverage (5x inverse exposure), which is well beyond UCITS limits for leverage and is a key complexity factor. The product uses derivatives inherently to achieve this inverse leveraged exposure, including swaps or similar instruments, introducing counterparty and collateral risks that are difficult for retail investors to understand. The replication method is synthetic, as the product does not physically hold the underlying bonds but replicates performance via derivatives. The product documentation explicitly warns about the compounding effect due to daily rebalancing, which can cause returns over longer holding periods to deviate significantly from the expected -5x multiple, adding to complexity. The product is not capital protected and carries a high risk rating (6/7), reflecting market and structural risks. The intended retail investor is described as sophisticated, able to monitor frequently, and aware of the risks of inverse leveraged products, indicating complexity. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features (significant leverage, synthetic replication, embedded derivatives, inverse exposure, and complex payoff structures) classify the product as complex. Therefore, an appropriateness assessment is required before sale to retail clients, and a comprehension alert is mandatory in the PRIIPs KID. This product does not meet the criteria for non-complex instruments under Article 57, notably due to leverage, derivative use integral to strategy, and complexity of payoff and risks."
}